FoxO1 target Gpr17 activates AgRP neurons to regulate food intake |
| |
Authors: | Ren Hongxia Orozco Ian J Su Ya Suyama Shigetomo Gutiérrez-Juárez Roger Horvath Tamas L Wardlaw Sharon L Plum Leona Arancio Ottavio Accili Domenico |
| |
Affiliation: | 1 Berrie Diabetes Center and Department of Medicine, Columbia University, New York, NY 10032, USA 2 Taub Institute and Department of Pathology and Cell Biology, Columbia University, New York, NY 10032, USA 3 Diabetes Research and Training Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA 4 Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06519, USA |
| |
Abstract: | Hypothalamic neurons expressing Agouti-related peptide (AgRP) are critical for initiating food intake, but druggable biochemical pathways that control this response remain elusive. Thus, genetic ablation of insulin or leptin signaling in AgRP neurons is predicted to reduce satiety but fails to do so. FoxO1 is a shared mediator of both pathways, and its inhibition is required to induce satiety. Accordingly, FoxO1 ablation in AgRP neurons of mice results in reduced food intake, leanness, improved glucose homeostasis, and increased sensitivity to insulin and leptin. Expression profiling of flow-sorted FoxO1-deficient AgRP neurons identifies G-protein-coupled receptor Gpr17 as a FoxO1 target whose expression is regulated by nutritional status. Intracerebroventricular injection of Gpr17 agonists induces food intake, whereas Gpr17 antagonist cangrelor curtails it. These effects are absent in Agrp-Foxo1 knockouts, suggesting that pharmacological modulation of this pathway has therapeutic potential to treat obesity. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|